Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3′-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Sams M A Sadat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2R3, Canada. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Irinotecan, Topoisomerase I Inhibitors, Micelles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Canadian Institutes of Health Research, Alberta Cancer Foundation, Ministry of Higher Education and Scientific Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
- Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut 71515, Egypt.
- Department of Chemistry, Faculty of Science, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
- Department of Oncology, Cross Cancer Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
- Department of Chemical and Material Engineering, University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
ORCID-Profile: Sams M A Sadat, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Förderung
- Canadian Institutes of Health Research
- Alberta Cancer Foundation
- Ministry of Higher Education and Scientific Research
- NanoMedicines Innovation Network
Zitieren
APA
Sadat, S. M. A., Vakili, M. R., Abd-El Hafeez, S. I., Paladino, M., Hall, D. G., Weinfeld, M., & Lavasanifar, A. (2024). Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3′-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00007
Vancouver
Sadat SMA, Vakili MR, Abd-El Hafeez SI, Paladino M, Hall DG, Weinfeld M, et al. Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3′-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00007
BibTeX
@article{Sadat2024,
author = {Sadat, Sams M A and Vakili, Mohammad Reza and Abd-El Hafeez, Sara I and Paladino, Marco and Hall, Dennis G and Weinfeld, Michael and Lavasanifar, Afsaneh},
title = {Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3′-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00007}
}
EUVIMED